Abstract:Transient receptor potential melastatin 2 (TRPM2), a non-selective cation channel, is involved in many physiological and pathological processes, including temperature sensing, synaptic plasticity regulation, and neurodegenerative diseases. However, the gating mechanism of TRPM2 channel is complex, which hinders its functional research. With the discovery of the Ca2+ binding site in the S2-S3 domain of TRPM2 channel, more and more attention has been drawn to the role of the transmembrane segments in channel gating. In this study, we focused on the D820-F867 segment around the S2 domain, and identified the key residues on it. Functional assays of the deletion mutants displayed that the deletions of D820-W835 and L836-P851 destroyed channel function totally, indicating the importance of these two segments. Sequence alignments on them found three polar and charged residues with high conservation (D820, E829, and R845). D820A, E829A, and R845A which removed the charge and the side chain of the residues were tested by 500 mu M adenosine diphosphate-ribose (ADPR) or 50 mM Ca2+. E829A and R845A affected the characteristic of channel currents, while D820A behaved similarly to WT, indicating the participations of E829 and R845 in channel gating. The charge reversing mutants, E829K and R845D were then constructed and the electrophysiological tests showed that E829A and E829K made the channel lose function. Interestingly, R845A and R845D exhibited an inactivation process when using 500 mu M ADPR, but activated normally by 50 mM Ca2+. Our data suggested that the negative charge at E829 took a vital part in channel activation, and R845 increased the stability of the Ca2+ combination in S2-S3 domain, thus guaranteeing the opening of TRPM2 channel. In summary, our identification of the key residues E829 and R845 in the transmembrane segments of TRPM2. By exploring the gating process of TRPM2 channel, our work helps us better understand the mechanism of TRPM2 as a potential biomarker in neurodegenerative diseases, and provides a new approach for the prediction, diagnosis, and prognosis of neurodegenerative diseases.

Critical Role of Trp-588 of Presynaptic Munc13-1 for Ligand Binding and Membrane Translocation

Mechanistic Insights into Neurotransmitter Release and Presynaptic Plasticity from the Crystal Structure of Munc13-1 C1C2BMUN.

Insights into Neurotransmitter Release from the Structure of Munc13-1 C1c2bmun

Control of Munc13-1 Activity by Autoinhibitory Interactions Involving the Variable N-terminal Region

Identification of Residues Critical for the Extension of Munc18-1 Domain 3A.

Mechanism that regulates the mutual inhibition controls functional switch of UNC-13

Munc13 Mediates the Transition from the Closed Syntaxin–munc18 Complex to the SNARE Complex

Functional Synergy Between the Munc13 C-terminal C1 and C2 Domains.

The crystal structure of a Munc13 C-terminal module exhibits a remarkable similarity to vesicle tethering factors.

Munc13-1 is a Ca2+-phospholipid-dependent vesicle priming hub that shapes synaptic short-term plasticity and enables sustained neurotransmission

A novel functional coordination in UNC-13 regulates neurotransmitter release

The identification of the key residues E829 and R845 involved in transient receptor potential melastatin 2 channel gating

The N-peptide–binding Mode is Critical to Munc18-1 Function in Synaptic Exocytosis

Beyond the MUN domain, Munc13 controls priming and depriming of synaptic vesicles

Dynamic Conformational Changes in MUNC18 Prevent Syntaxin Binding

Characterization of a novel MgtE homolog and its structural dynamics in membrane mimetics

Insights into Ligand-Mediated Activation of an Oligomeric Ring-Shaped Gene-Regulatory Protein from Solution- and Solid-State NMR

Binding of Munc18-1 to Synaptobrevin and to the Snare Four-Helix Bundle

Cryo-EM Structures of the Mammalian Endo-Lysosomal TRPML1 Channel Elucidate the Combined Regulation Mechanism

Activating Mutations Reveal A Role Of Trpml1 In Lysosomal Exocytosis

Munc18-1 Protein Molecules Move Between Membrane Molecular Depots Distinct from Vesicle Docking Sites*